Skip to main content
. 2020 Dec 17;16(5):523–531. doi: 10.1159/000510468

Fig. 1.

Fig. 1

The consort diagrams depict the eligibility of the patients and the respective samples that were included in the 2 patient cohorts, i.e., the anthracycline-based chemotherapy treated cohort (A) and the untreated cohort (B), and the reasons for noninclusion.